Obese Patients With Bariatric Surgery
Conditions
Keywords
obese patients, nausea and vomiting, cold application
Brief summary
Obesity is a chronic disease resulting from an excess of body fat mass relative to lean body mass, characterized by a deterioration in the individual's quality of life and health (Kayar and Utku, 2013; Usta and Çavdar, 2013; Tam and Çakır, 2012; Tuncalı et al., 2018). Bariatric surgery is becoming increasingly common worldwide. Nausea and vomiting are among the most frequently observed complications in these patients. This study will be conducted to assess patients for the risk of nausea and vomiting and to examine the effects of a cold application nursing intervention. The lack of sufficient literature measuring nausea and vomiting in patients following bariatric surgery prompted us to undertake this study.
Detailed description
The analysis of the patients' pre- and post-operative scale scores in this study is expected to reveal an improvement in quality of life, consistent with the findings of similar studies. It is anticipated that the patients' quality of life will increase as they achieve their desired weight and body image, gain mobility, and become more independent in their daily lives. Quality of life is defined as the level of satisfaction shaped by an individual's abilities and lifestyle. Obesity frequently impacts quality of life negatively by affecting the individual psychosocially-particularly through dissatisfaction with their physical appearance.
Interventions
OTHERICE
Upon the individual's arrival at the unit, the status of nausea (including severity) and vomiting was assessed, and physiological parameters were measured. A cold compress wrapped in gauze was applied to the patient's upper neck area and left in place for five minutes. Following the procedure, the status of nausea (including severity), vomiting, and physiological parameters was re-evaluated. The use of antiemetic and opioid medications was also recorded.
Sponsors
Sakarya University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Subject)
Intervention model description
Patients are transferred to the gastrointestinal surgery ward following their surgery. Postoperative Metpamid (10 mg/2 mL) is routinely administered to prevent postoperative nausea and vomiting (PONV). Upon arrival at the ward, patients' vital signs are checked by a nurse and recorded in the observation chart. Treatments prescribed by the physician are administered and documented. If patients are sufficiently motivated and their pain is controlled, they are mobilized after the 4th or 6th hour and continue walking every two hours during the first day following mobilization.
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Individuals over the age of 18 * Patients accessible prior to surgery * Those scheduled to receive general anesthesia only * Conscious individuals * Individuals without cognitive or psychiatric disorders
Exclusion criteria
* Individuals under the age of 18 * Those who experienced serious complications during or after surgery * Individuals with hearing, visual, speech, or cognitive dysfunction * Those without neurological problems * Patients who do not consent to the procedure
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Visual Analogue Scale (VAS) | 15 months | The VAS is a scale ranging from 0 ("no nausea") to 10 ("very severe nausea"), with numerical values assigned at one-centimeter intervals. The following were rated: nausea severity, peak nausea severity, nausea severity during activity, nausea severity at rest, retching/vomiting severity, and peak retching/vomiting severity. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Apfel Nausea and Vomiting Risk Score | 15 MONTHS | To predict the development of postoperative nausea and vomiting, the Apfel Risk Score assesses four factors: female gender, non-smoking status, a history of postoperative nausea and vomiting or motion sickness, and postoperative opioid use. Each factor is assigned 1 point. The Apfel risk score ranges from 0 to 4 and is classified into low, moderate, and high-risk categories. An Apfel risk score of 0-1 indicates low risk, 2 indicates moderate risk, and 3-4 indicates high risk. |
Countries
Turkey (Türkiye)
Contacts
PRINCIPAL_INVESTIGATORÖzlem Doğu, PhD
Sakarya University
Outcome results
None listed